BIO-GENE TECHNOLOGY LTDBIO-GENE TECHNOLOGY LTDBIO-GENE TECHNOLOGY LTD

BIO-GENE TECHNOLOGY LTD

No trades
See on Supercharts

BGT fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Bio-Gene Technology Ltd. engages in the research and development of the next generation of novel insecticides, addressing the problems of insecticide resistance and toxicity. Its novel platform technology is based on occurring beta-triketones, a type of chemistry that may offer solutions for insect management control in animal health and crop protection as well as in public health applications. The company was founded on November 8, 1995 and is headquartered in Melbourne, Australia.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
BGT has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company